| Autori: |
Uryu H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Saeki K; Tokyo University of Science, Division of Integrated Research, Research Institute for Biomedical Sciences, Noda, Japan., Haeno H; Tokyo University of Science, Division of Integrated Research, Research Institute for Biomedical Sciences, Noda, Japan., Kapadia CD; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA., Furudate K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nangalia J; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Spencer Chapman M; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Barts Cancer Institute, Queen Mary University of London, London, UK., Zhang L; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA., Padilla J; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA., Zhao L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hsu JI; Department of Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Zhao C; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chen S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tanaka T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Li Z; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ogata S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hanache S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yang H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., DiNardo C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Song X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Thompson E; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tang H; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Little L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gumbs C; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Orlowski RZ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Qazilbash M; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bhalla K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Colla S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bueso-Ramos C; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nakada D; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA., Al-Atrash G; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Molldrem J; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shpall E; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Goodell M; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ktakahashi@mdanderson.org.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ktakahashi@mdanderson.org. |
Nájsť tento článok vo Web of Science